Showing results (1911-1920 of 2,722) with videos related to
Sort By:
Pageof 273
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 10, 2024
Therapeutic strategies aiming at the reduction of the antiplatelet intensity should not overlook the ischemic risk in patients with coronary syndromesLuca Scorpiglione, Jacopo Pizzicannella, Elena Bacigalupi, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 10, 2024
The impact of elevated C-reactive protein levels on long-term outcomes of patients undergoing transcatheter aortic valve replacementStephanie Brunner, Federico Moccetti, Lucca Loretz, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 28, 2024
Performance of balloon-expandable transcatheter bioprostheses in inoperable patients with pure aortic regurgitation of a native valve: The BE-PANTHEON international projectEnrico Poletti, Ignacio Amat-Santos, Enrico Criscione, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 21, 2024
Risk factors for early mortality following transcatheter edge-to-edge repair of mitral regurgitationYong-Hao Yeo, Jia-Yean Thong, Min-Choon Tan, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 29, 2024
Impact of left bundle branch block or permanent pacemaker after transcatheter aortic valve replacement on mid-term left ventricular ejection fractionIlan Merdler, Brian C Case, Itsik Ben-Dor, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 29, 2024
Outcomes following TAVR in patients with cardiogenic shock: A systematic review and meta-analysisAhmad Jabri, Mohammed Ayyad, Maram Albandak, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 27, 2024
Adverse outcomes with left atrial appendage occlusion device implantation in chronic and end stage kidney disease: A systemic review and meta-analysisGauravpal S Gill, Shikha Shailly, Teja Chakrala, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 29, 2024
Haemodynamic and clinical outcomes at 5 years according to predicted prosthesis-patient mismatch after transcatheter aortic valve replacementYoichi Sugiyama, Hirokazu Miyashita, Tomoki Ochiai, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 16, 2024
A multimodal approach to predict prosthesis-patient mismatch in patients undergoing valve-in-valve trans-catheter aortic valve implantationFrancesco Bianchini, Enrico Romagnoli, Cristina Aurigemma, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 3, 2024
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trialAntonio Popolo Rubbio, Luca Testa, Carlo A Pivato, et al.Pageof 273